Medicago to launch clinical trials for COVID-19 vaccine candidate with GSK’s pandemic adjuvant in Japan
Read more
-
-
Medicago and GSK announce positive interim phase 2 results for adjuvanted COVID-19 vaccine candidate
Read more -
Medicago and GSK start phase 3 trial of adjuvanted COVID-19 vaccine candidate
Read more -
Medicago and GSK announce start of phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
Read more -
Medicago announces positive phase 1 results for its COVID-19 vaccine candidate
Read more -
Medicago begins phase 1 clinical trials for its COVID-19 vaccine candidate
Read more -
Medicago announces Phase 3 study of VLP quadrivalent influenza vaccine
Read more